Tonix Pharmaceuticals Holding Corp. (TNXP) Cash flow
Market cap
$122.55M
P/E ratio
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 4 | 3 |
| Stock-based compensation | 686,713 | 2 | 3 | 3 | 4 | 3 | 2 | 1 | 3 | 8 | 11 | 9 | 5 |
| Cash from operations | -2,637,538 | -5,712,864 | -9 | -23 | -43 | -37 | -19 | -27 | -49 | -76 | -98 | -102 | -61 |
| Capital expenditures | -42,862 | -78,535 | -0 | -0 | -0 | -0 | -0 | -0 | -9 | -35 | -48 | -8 | -0 |
| Cash from investing | 302 | -35,763 | -0 | -0 | -24 | 17 | 7 | -0 | -9 | -35 | -48 | -29 | -0 |
| Repurchases of common stock | - | - | - | - | - | - | - | - | - | - | - | 14 | - |
| Repayments of term debt | - | - | - | - | - | - | - | - | - | - | - | - | 2 |
| Cash from financing | 5 | 12 | 27 | 53 | 48 | 20 | 19 | 13 | 123 | 212 | 88 | 37 | 135 |
| Free cash flow | |||||||||||||
| FCF margin (%) | - | - | - | - | - | - | - | - | - | - | - |